Title: Clinical features of 32 diffuse large B-cell lymphoma of the tonsi
Abstract: Objective To investigate the clinical features of 32 difuse large B-cell iymphoma of the tonsil and explore the influence factors on the prognosis.Methods The clinical features and effect of treatment of 32 cases of difuse large B-cell lymphoma of the tonsil were analyzed.The influence factors on the prognosis were explored.23(71.87%)patients with Stage Ⅰ-Ⅱ received diochemotherapy-predominant treatment,whereas patients with stage Ⅲ-Ⅳ received chemotherapy-predominant treatment.The combined chemotherapy included of CHOP or RCHOP.Results Rituximab can increase the therapeutic efficacy of CHOP regimen on diagnosed patients with difuse large B-cell lymphoma of the tonsil.The 5 years survival rate of stage Ⅰ-Ⅱ patients was 81.23% and stage Ⅲ,Ⅳ patients was 57.26%.The prognosis analysis showed that the prognosis had association with the age,stage and LDH level.Conclusion Most patients with difuse large B-cell lymphoma of the tonsil are at early stages with good prognosis;RCHOP regimen combined with radiotherapy may be a proper treatment;Age,stage and LDH level are the important factors which affect on diffuse large B-cell lymphoma prognosis.
Publication Year: 2010
Publication Date: 2010-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot